Why 80% of Clinical Trials Fail to Enroll on Time — And What That Means for Patients
Published April 6, 2026 · ClinicalTrials.gov data
There are 7,801 clinical trials actively recruiting participants right now. Most of them are struggling to find enough people. This is not a minor administrative problem — it is a crisis that delays treatments, increases costs, and means millions of patients never learn about options that could help them.
Important: This is educational information, not medical advice. Talk to your doctor about whether a clinical trial is right for you.
The Enrollment Crisis in Numbers
The gap between how many patients need to enroll and how many actually do is staggering:
of clinical trials fail to meet enrollment deadlines
longer than planned — the average enrollment delay
of Phase 3 trials fail due to insufficient enrollment alone
In oncology, the numbers are particularly stark: 76% of cancer patients say they would be willing to participate in a clinical trial, but only 3-5% actually enroll. That is a gap of over 70 percentage points between willingness and action — and most of it comes down to systemic barriers, not patient reluctance.
The Four Barriers to Enrollment
1. Awareness: Patients Do Not Know Trials Exist
The most fundamental barrier is the simplest: patients cannot join trials they do not know about. Research shows that fewer than 25% of patients are aware that clinical trials may be an option for their condition. Many doctors do not mention trials during appointments — not out of negligence, but because the volume of active trials makes it difficult to stay current across 2540 conditions.
This is exactly the gap that tools like TrialFinder are designed to close. We index 7,801 trials from ClinicalTrials.gov and translate their eligibility criteria into plain English so patients can explore their options independently.
2. Access: Trials Are Concentrated in Cities
Clinical trial sites are disproportionately located at academic medical centers in major metropolitan areas. If you live in a rural area, the nearest trial site for your condition may be hours away. Travel, lodging, and time away from work create real financial barriers — a 2024 study found that trial participants incur an average of $3,600 in out-of-pocket costs related to transportation and lodging alone.
Decentralized trials (where some visits happen remotely or at local clinics) are growing but still represent a minority of active studies.
3. Mistrust: Historical Harm and Lack of Diversity
Clinical research has a troubled history with underrepresented communities. The legacy of the Tuskegee syphilis study and other abuses has created justified skepticism. Today, minority populations remain underrepresented in clinical trials: Black patients make up 13% of the U.S. population but only 5% of trial participants. Hispanic patients make up 19% of the population but represent just 6% of enrollees.
This is not just an equity issue — it is a scientific one. If a treatment is only tested in one demographic, we cannot know whether it works the same way in others.
4. Complexity: Eligibility Criteria Exclude Too Many People
Clinical trial eligibility criteria have historically been narrow — excluding patients with common comorbidities like diabetes, prior cancers, or organ impairment. Studies have found that up to 85% of patients who express interest in a trial are screened out by eligibility criteria. Many of these exclusions exist to simplify data analysis rather than for genuine safety reasons.
The FDA has recognized this problem and issued updated guidance in December 2025 encouraging sponsors to broaden eligibility criteria. Read more in our article on how the FDA is making trials more inclusive.
What This Means for You
Here is the encouraging takeaway: clinical trials need more participants, which means there are more opportunities for patients than most people realize. If you have a condition with limited treatment options, there may be trials actively searching for someone with your profile.
The enrollment gap also means that trial sites are increasingly motivated to make participation easier — offering travel stipends, remote monitoring, flexible scheduling, and clearer communication about what participation involves.
How to Take the Next Step
- Search for your condition — browse TrialFinder or ClinicalTrials.gov to see what is recruiting near you
- Ask your doctor — bring up clinical trials at your next appointment and ask if any are relevant
- Read the eligibility criteria carefully — our eligibility guide explains common criteria in plain English
- Do not self-exclude — criteria are evolving. Even if you were ineligible for a trial last year, new trials with broader criteria may be recruiting now
Frequently Asked Questions
Why do so few people participate in clinical trials?
The biggest barriers are awareness (most patients do not know trials exist for their condition), access (trials are concentrated at academic medical centers in major cities), mistrust (historical abuses and lack of diversity in research), and complexity (eligibility criteria can exclude up to 85% of patients who apply). These are systemic issues, not patient failures.
What percentage of clinical trials fail to enroll enough participants?
Approximately 80% of clinical trials fail to meet their enrollment deadlines. About 30% of Phase 3 trials fail solely due to insufficient enrollment, not because the treatment did not work. On average, trials take 60% longer than planned to reach their enrollment targets.
Does low enrollment delay new treatments from reaching patients?
Yes, significantly. When a trial cannot enroll enough participants, the entire drug development timeline extends. This delays FDA review and approval, meaning patients who could benefit from new treatments must wait longer. Some promising treatments are abandoned entirely when sponsors cannot justify the cost of extended enrollment timelines.
How can I find out if there is a clinical trial for my condition?
Start by asking your doctor, who can refer you to relevant trials. You can also search ClinicalTrials.gov directly or use tools like TrialFinder that translate eligibility criteria into plain English. Many academic medical centers have trial matching services that can help identify options for your specific situation.
About This Data
Enrollment statistics from published research (CISCRP, Tufts Center for the Study of Drug Development, and ASCO). Trial counts from ClinicalTrials.gov API v2. We track 7,801 recruiting trials across 2540 conditions. This is educational information — talk to your doctor about clinical trials. See our methodology.